Clinical Trials Browser

Completed × Neoplasms × Arsenic Trioxide × Clear all

NCT00250042 2011-09-20

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Neoplasms